Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese

Environmental Health and Preventive Medicine

Volumn 17, Issue 5, 2012, Pages 371-376

  Mori, Yayoi ^a   Sugawara, Akiko ^a   Tsuji, Masayoshi ^a   Kakamu, Takeyasu ^a   Tsuboi, Satoshi ^a   Kanda, Hideyuki ^a   Hayakawa, Takehito ^a   Fukushima, Tetsuhito ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytotoxicity; Manganese; Mouse CD1 brain striatum neuronal cells; Nicotinamide N methyltransferase; Parkinson's disease

Indexed keywords

1 METHYLNICOTINAMIDE; MANGANESE; NICOTINAMIDE; NICOTINAMIDE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; ENZYME ACTIVITY; METHYLATION; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; VITAMIN METABOLISM;

ANIMALS; CELL SURVIVAL; DITHIOTHREITOL; MANGANESE; METHYLATION; MICE; NEOSTRIATUM; NIACINAMIDE; NICOTINAMIDE N-METHYLTRANSFERASE;

EID: 84869506759     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-011-0262-6     Document Type: Article

References (28)

1. De Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63:1240-4.
2. Japan Intractable Diseases Information Center. Available at: http://www.nanbyou.or.jp/. Accessed 20 Sept 2011.
3. Rao SS, Hofmann LA, Shakil A. Parkinson's disease: diagnosis and treatment. Am Fam Phys. 2006;74:2046-54.
4. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine analog synthesis. Science. 1983;219:979-80.
5. Gearhart DA, Neafsey EJ, Collins MA. Characterization of brain beta-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem Res. 1997;22: 113-21.
6. Kotake Y. Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances (in Japanese). Yakugaku Zasshi. 2002;122:975-82.
7. Naoi M, Dostert P, Yoshida M, Nagatsu T. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins. Adv Neurol. 1993;60:212-7.
8. Williams AC, Ramsden DB. Autotoxicity, methylation and a road to the prevention of Parkinson's disease. J Clin Neurosci. 2005; 12:6-11.
9. Fukushima T, Tawara T, Isobe A, Hojo N, Shiwaku K, Yamane Y. Radical formation site of cerebral complex I and Parkinson's disease. J Neurosci Res. 1995;42:385-90.
10. Fukushima T, Kaetsu A, Lim H, Moriyama M. Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp Toxicol Pathol. 2002;53:469-73.
11. Jonathon MW, Joseph L, Adrian CW, Helen RG. Neurotoxicity of nicotinamide derivatives; their role in the aetiology of Parkinson's disease. Biochem Soc Trans. 1993;21:299S.
12. Williams A, Ramsden D. Nicotinamide: a double edged sword. Parkinsonism Relat Disord. 2005;11:413-20.
13. Yan L, Otterness DM, Weinshilboum RM. Human nicotinamide Nmethyltransferase pharmacogenetics: gene sequence analysis and promoter characterization. Pharmacogenetics. 1999;9:307-16.
14. Sugawara A, Yokoyama H, Ohta M, Maeda T, Tanaka K, Fukushima T. The effect of heavy metals on nicotinamide N-methyltransferase activity in vitro relating to Parkinson's disease. Environ Health Prev Med. 2005;10:180-3.
15. Sato K, Ueyama H, Arakawa R, Kumamoto T, Tsuda T. A case of welder presenting with parkinsonism after chronic manganese exposure. Rinsho Shinkeigaku. 2000;40:1110-5 (in Japanese).
16. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003;60:1761-6.
17. Fukushima T, Kanda H, Tan X, Luo Y. Relationship between blood levels of heavy metals and Parkinson's disease in China. Neuroepidemiology. 2010;34:18-24.
18. Sadek AH, Rauch R, Schulz PE. Parkinsonism due to manganism in a welder. Int J Toxicol. 2003;22:393-401.
19. Nagatomo S, Umehara F, Hanada K, Nobuhara Y, Takenaga S, Arimura K, et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci. 1999;162:102-5.
20. Stanwood GD, Leitch DB, Savchenko V, Wu J, Fitsanakis VA, Anderson DJ, et al. Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem. 2009;110:378-89.
21. Aschner M, Erikson KM, Dorman DC. Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol. 2005;35:1-32.
22. Gwiazda RH, Lee D, Sheridan J, Smith DR. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology. 2002;23:69-76.
23. Ogata S, Takeuchi M, Okumura K, Taguchi H. Apoptosis induced by niacin-related compounds in HL-60 cells. Biosci Biotechnol Biochem. 1998;62(12):2351-6.
24. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem. 1996;271:32599-604.
25. Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB. Expression of nicotinamide N-methyltransferase (E.C.2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol. 2002;61: 111-24.
26. Slomka M, Zieminska E, Lazarewicz JW. Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells. Acta Neurobiol Exp. 2008;68:1-9.
27. Slomka M, Zieminska E, Salinska E, Lazarewicz JW. Neuroprotective effects of nicotinamide and 1-methylnicotinamide in acute excitotoxicity in vitro. Folia Neuropathol. 2008;46:69-80.
28. Kamat JP, Devasagayam TP. Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria. Redox Rep. 1999;4:179-84.